The Personalized Medical Devices Market: By Therapeutic Area (Neurology, Oncology, Cardiology, Psychiatry, Antiviral, Others) By Application (Companion Diagnostics, Biomarker identification, Health Informatics, Clinical Research), By End User(Hospitals, Molecular Diagnostic Laboratories and Testing facilities, Homecare settings, Others), By Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

The global Personalized Medical Devices Market size was valued at USD 494.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.3% from 2022 to 2028. Personalized Medical Devices (PM) can possibly tailor made devices with the best reaction and most noteworthy security edge to guarantee better patient care. By empowering every patient to get prior judgments, chance appraisals, and ideal medications, Personalized Medical Devices Market holds guarantee for enhancing medicinal services while additionally bringing down expenses. Medical devices companies are encountering aggressive and taken a toll weight from various sides. On one hand, rivalry emerging from developing markets requests high-volume, straightforward gadgets with bring down costs, applying weight on costs all around. Then again, organizations confront aggressive weight from new wellsprings of medicinal gadget development like added substance fabricating, which empowers unique produce of patient-particular careful instruments and implants. Some of the examples for personalized medical devices Tinnitus masker is customized by the producer to understanding tinnitus.The tinnitus treatment custom-tailors the sound signs to suit the individual patient's listening ability necessities Pedicle screw spinal frameworks – Spinal frameworks comprising of a bar/screw/snare/connector unit are amassed by a specialist to oblige a patient's interesting life systems/physiology utilizing MRI/CT imaging. Programming based quantitative EEG investigation intended to anticipate a person's reaction to different psychotropic medications. The gadget gives the likelihood of reaction to different solutions to direct clinician in basic leadership. The Zenith Fenestrated AAA Endovascular Graft is demonstrated for the endovascular treatment of patients with stomach aortic or aortoiliac aneurysms having morphology reasonable for endovascular repair. The fenestrated gadget takes into account treatment of patients with shorter proximal neck lengths (i.e., length of solid aorta between the renal corridors and the aneurysm) when contrasted with the individuals who can be dealt with utilizing other endovascular joins. Every gadget is customized to the patient's individual aortic life structures with openings in the join material set suitably to keep up blood stream to branch vessels of the aorta. The Artificial Pancreas Device System is a gadget under clinical examination that naturally screens understanding glucose levels and conveys persistent customized insulin measurements in individuals with diabetes.

Personalized Medical Devices Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Market Dynamics

Personalized Medical Devices market is relied upon to witness fast development because of expanding illness occurrence and profound focal point of launching new products for tumor patients where viability has been turned out to be higher when contrasted with different treatments. Quick outcomes and tweaked impacts, bring down likelihood of prescription defects and unfriendly medication responses are a portion of alternate factors that could make reasonable footing in both R&D and income potential for these solutions. Late advancements in the pharmacogenomics are relied upon to make appropriate condition for developing devices, which are particular to one patient or gathering. Advancement of hereditary databases could give extra lift to the market. Up and coming remedial application openings in fields, for example, cardio-renal, neurology, antiviral, pneumonic, psychiatry among others could make R&D footing over all locales. High advancement costs, problematic improvement structure and between understanding changeability of impacts are a portion of the limitations that could hamper income development of the Personalized Medical Devices market.

Key Features of the Reports

  • Global Personalized Medical Devices Market expanding at significant CAGR over 2022 to 2028 due to increase in the awareness to providing effective communication to the consumers.
  • Based on of therapeutic area, application, end user Personalized Medical Devices segment accounted for larger market revenue share in 2021 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global Personalized Medical Devices Market market

Personalized Medical Devices Market Segmentation

by Therapeutic Area
  • Neurology
  • Oncology
  • Cardiology
  • Psychiatry
  • Antiviral
  • Others
By Application
  • Companion Diagnostics
  • Biomarker identification
  • Health Informatics
  • Clinical Research
by End User
  • Hospitals
  • Molecular Diagnostic Laboratories and Testing facilities
  • Homecare settings
  • Others
By Geography
North America
  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe
  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific
Latin America
  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America
Middle East and Africa (MEA)
  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Becton, Dickinson and Company (USA)
  • Abbott Laboratories, Inc. (USA)
  • bioMerieux, Inc. (France)
  • Biomerica, Inc.(USA)
  • Olympus Corporation (Japan)
  • Qiagen N.V. (Geramany)
  • Siemens AG (Germany)
  • Thermo Fischer Scientific, Inc. (USA).